advertisement
Rhodes LA 21
Showing records 1 to 21 | Display all abstracts from Rhodes LA98684 Cost Utility of Schlemm's Canal Microstent Injection with Cataract Surgery for Open Angle Glaucoma in the United States Medicare System
Atik A
Journal of Glaucoma 2022; 31: 413-422
99112 Clinicians' Use of Quantitative Information when Assessing the Rate of Functional Progression in Glaucoma
Gardiner SK
Ophthalmology. Glaucoma 2022; 5: 498-506
98788 Clinicians' Use of Quantitative Information When Assessing the Rate of Structural Progression in Glaucoma
Gardiner SK; Kinast RM
Ophthalmology. Glaucoma 2022; 5: 507-515
98684 Cost Utility of Schlemm's Canal Microstent Injection with Cataract Surgery for Open Angle Glaucoma in the United States Medicare System
Rhodes LA
Journal of Glaucoma 2022; 31: 413-422
99112 Clinicians' Use of Quantitative Information when Assessing the Rate of Functional Progression in Glaucoma
Kinast RM; De Moraes CG
Ophthalmology. Glaucoma 2022; 5: 498-506
98788 Clinicians' Use of Quantitative Information When Assessing the Rate of Structural Progression in Glaucoma
Chen TC
Ophthalmology. Glaucoma 2022; 5: 507-515
98684 Cost Utility of Schlemm's Canal Microstent Injection with Cataract Surgery for Open Angle Glaucoma in the United States Medicare System
Samuels BC
Journal of Glaucoma 2022; 31: 413-422
98788 Clinicians' Use of Quantitative Information When Assessing the Rate of Structural Progression in Glaucoma
Strouthidis NG
Ophthalmology. Glaucoma 2022; 5: 507-515
98684 Cost Utility of Schlemm's Canal Microstent Injection with Cataract Surgery for Open Angle Glaucoma in the United States Medicare System
Mennemeyer ST
Journal of Glaucoma 2022; 31: 413-422
99112 Clinicians' Use of Quantitative Information when Assessing the Rate of Functional Progression in Glaucoma
Budenz DL; Jeoung JW
Ophthalmology. Glaucoma 2022; 5: 498-506
98684 Cost Utility of Schlemm's Canal Microstent Injection with Cataract Surgery for Open Angle Glaucoma in the United States Medicare System
Girkin CA
Journal of Glaucoma 2022; 31: 413-422
98788 Clinicians' Use of Quantitative Information When Assessing the Rate of Structural Progression in Glaucoma
De Moraes CG; Nouri-Mahdavi K
Ophthalmology. Glaucoma 2022; 5: 507-515
99112 Clinicians' Use of Quantitative Information when Assessing the Rate of Functional Progression in Glaucoma
Lind JT
Ophthalmology. Glaucoma 2022; 5: 498-506
98788 Clinicians' Use of Quantitative Information When Assessing the Rate of Structural Progression in Glaucoma
Myers JS
Ophthalmology. Glaucoma 2022; 5: 507-515
99112 Clinicians' Use of Quantitative Information when Assessing the Rate of Functional Progression in Glaucoma
Myers JS; Nouri-Mahdavi K
Ophthalmology. Glaucoma 2022; 5: 498-506
98788 Clinicians' Use of Quantitative Information When Assessing the Rate of Structural Progression in Glaucoma
Jeoung JW
Ophthalmology. Glaucoma 2022; 5: 507-515
99112 Clinicians' Use of Quantitative Information when Assessing the Rate of Functional Progression in Glaucoma
Rhodes LA
Ophthalmology. Glaucoma 2022; 5: 498-506
98788 Clinicians' Use of Quantitative Information When Assessing the Rate of Structural Progression in Glaucoma
Lind JT; Rhodes LA
Ophthalmology. Glaucoma 2022; 5: 507-515
99112 Clinicians' Use of Quantitative Information when Assessing the Rate of Functional Progression in Glaucoma
Strouthidis NG; Chen TC
Ophthalmology. Glaucoma 2022; 5: 498-506
98788 Clinicians' Use of Quantitative Information When Assessing the Rate of Structural Progression in Glaucoma
Budenz DL; Mansberger SL
Ophthalmology. Glaucoma 2022; 5: 507-515
99112 Clinicians' Use of Quantitative Information when Assessing the Rate of Functional Progression in Glaucoma
Mansberger SL
Ophthalmology. Glaucoma 2022; 5: 498-506
